跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLN-ATOVAQUONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
GLN-ATOVAQUONE
Authorized
STANDARD
GLN-ATOVAQUONE
glenmark pharmaceuticals canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2eff30aebcf85e30
Company
glenmark pharmaceuticals canada inc.
Type
Standard
Approval Details
Approval Id
2eff30aebcf85e30
Drug Approval Canada Name
GLN-ATOVAQUONE
Product Name
GLN-ATOVAQUONE
Status
Marketed
Status Date
2022-06-30
Original Market Date
2022-06-30
Din
02528495
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:30.92
Atc Original
P01AX06 ATOVAQUONE
Atc Name
p 01 ax 06
Aig Number
0124073001
Company Name
glenmark pharmaceuticals canada inc.
Company Address
1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2
Active Ingredients
ATOVAQUONE
750 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2eff30aebcf85e30
Type
Standard
Back to Health Canada Approvals